Armstrong Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.9M Buy
6,825
+102
+2% +$120K 0.48% 26
2026
Q2
$8.06M Sell
6,723
-28
-0.4% -$28.6K 0.49% 29
2026
Q1
$6.21M Sell
6,751
-1,442
-18% -$1.46M 0.42% 30
2025
Q4
$8.8M Sell
8,193
-577
-7% -$552K 0.6% 29
2025
Q3
$6.69M Buy
8,770
+3,062
+54% +$2.28M 0.47% 30
2025
Q2
$4.45M Sell
5,708
-284
-5% -$221K 0.34% 36
2025
Q1
$4.63M Hold
5,992
– – 0.37% 33
2024
Q4
$4.63M Sell
5,992
-38
-0.6% -$31.5K 0.37% 33
2024
Q3
$5.34M Sell
6,030
-191
-3% -$172K 0.44% 32
2024
Q2
$5.63M Sell
6,221
-202
-3% -$162K 0.5% 29
2024
Q1
$3.74M Hold
6,423
– – 0.36% 34
2023
Q4
$3.74M Buy
6,423
+6
+0.1% +$3.5K 0.36% 34
2023
Q3
$3.45M Sell
6,417
-36
-0.6% -$18.6K 0.38% 31
2023
Q2
$3.03M Sell
6,453
-106
-2% -$44.5K 0.32% 32
2023
Q1
$2.25M Sell
6,559
-45
-0.7% -$15.2K 0.27% 33
2022
Q4
$2.42M Buy
+6,604
New +$2.34M 0.32% 37

Other funds holding LLY

Armstrong Advisory Group's LLY Position: Q3 2026 in Review

Armstrong Advisory Group increased its Eli Lilly (LLY) stake by 1.5% in Q3 2026, buying an estimated $120K and bringing the position to 6,825 shares worth $7.9M. The position accounts for 0.48% of the portfolio, ranked #26.

Armstrong Advisory Group first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $8.8M in Q4 2025. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Armstrong Advisory Group held 6,825 shares of Eli Lilly worth $7.9M as of Q3 2026.
  • Armstrong Advisory Group bought 102 Eli Lilly shares in Q3 2026, an estimated $120K.
  • Eli Lilly made up 0.48% of Armstrong Advisory Group's portfolio in Q3 2026, its #26 holding.
  • Armstrong Advisory Group first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • Armstrong Advisory Group's Eli Lilly position peaked at $8.8M in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.